Hadassah

Delegates from Indonesia, Sri Lanka, and India Learn About Trauma Care at Hadassah

Friday, Jan 22 2016

Prof. Avi Rivkind, head of Hadassah’s Trauma Unit and one of its founders in 1991, describing Hadassah’s protocols for trauma treatment and the role Hadassah teams play in treating victims.

A team of experts in treating victims of natural disasters from Indonesia, Sri Lanka, and India visited the Hadassah Medical Center to learn how Hadassah copes with trauma and mass casualty events. Many in the delegation were senior physicians and government officials.

Prof. Avi Rivkind, head of Hadassah’s Trauma Unit and one of its founders in 1991, described Hadassah’s protocols for trauma treatment and the role Hadassah teams play in treating victims of tsunamis, earthquakes, and floods abroad. The visitors showed much interest in treatment protocols, how the work was divided among the medial staff, as well as Hadassah’s neurologic and orthopedic rehabilitation.

Delegates from Sri Lanka were surprised to hear that Prof. Rivkind had visited their country in 2004 to help victims of that year’s tsunami.

The visit was initiated and organized by the American Jewish Committee, which works to establish ties with many governments and countries under its Project Interchange, launched 40 years ago. Every year, some 35 delegations of non-Jewish opinion leaders come to Israel for an educational seminar to learn about the country.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More